SENATE FLOOR VERSION - HB2787 SFLR Page 1
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
April 13, 2023
COMMITTEE SUBSTITUTE
FOR ENGROSSED
HOUSE BILL NO. 2787 By: Stinson of the House
and
Rogers of the Senate
[ public health - stem cell research - report -
effective date ]
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 1-270.2, is
amended to read as follows:
Section 1-270.2 A. For the purposes of the Advan cement in Stem
Cell Cures and Therapies Act, “human embryo” means a living organism
of the species Homo sapiens at the earliest stage of developme nt,
including the single -cell stage, that is not located in the body of
a woman.
B. Research on human tissue regeneration and human diseases
using adult stem cells an d stem cells obtained from umbilical cord
blood and amniotic fluid may be conducted in th is state, provided
that the research is performed:
1. Safely and ethically;
SENATE FLOOR VERSION - HB2787 SFLR Page 2
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. Only on embryonic stem cell l ines created prior to August 1,
2001, and in accordance w ith federal law as it existed on November
1, 2007; and
3. Without the use of a human emb ryo, including a human embryo
produced using cloning technology.
C. When research is performed in accordance with the
Advancement in Stem Cell Cures and Therapies Act , a person or
governmental body shall not:
1. Restrict public funds designated for the s tem cell research;
or
2. Obstruct or provide disincentives for the stem cell
research.
D. The State Department of Health shall establish a reporting
system that collects information regarding all activities carried
out in accordance with this section.
E. The Department shall submit a report with all information
collected pursuant to subsection D of t his section to the Governor,
the Speaker of the Oklahoma House of Representatives, and the
President Pro Tempore of the State Senate no later than December 3 1
of each year every fifth year.
SECTION 2. This act shall become effective Novemb er 1, 2023.
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVI CES
April 13, 2023 - DO PASS AS AMENDED BY CS